Referral

Acute sinusitis

Scope

This guidance covers sinusitis of less than 3 months duration. Usually follows viral upper respiratory tract infection (URTI).

Out of scope

Sinusitis of more than 3 months duration – see guideline: Chronic rhinosinusitis with or without polyps

Toggle all

Signs and Symptoms

Symptoms include:

  • Blocked nose
  • Nasal discharge or post nasal drip
  • Reduced sense of smell or taste
  • Facial pain (facial pain in the absence of nasal symptoms is unlikely to be due to sinusitis)

Differential Diagnoses

If patient presents with persistent bloody discharge or progressive unilateral symptoms a 2ww referral should be made.

If suspicion of orbital or intracranial complications same day urgent referral to ENT.

Patients with a swollen red eye and acute sinusitis maybe suffering from orbital infection should be admitted immediately.

Plain sinus x ray not indicated.

Realistic expectation of symptom duration: 14-21 days is normal for acute sinusitis

Initial management supportive:

Persistent (more than 5 days) or severely or rapidly deteriorating symptoms:
In addition to above

Non resolutions in 14 days consider:

  • Change antibiotic and cover beta lactamase producing and anaerobic organisms

Formulary Chapter 12.2 Nose

Referral Criteria

Refer for specialist assessment
  • Failure of uncomplicated acute sinusitis to respond to above treatment within 4-6 weeks
  • Acute sinusitis with complications discuss with on-call ENT surgeon via switchboard

Referral Instructions

Information to include in referral
  • History and treatment as per guidance
  • Any significant dental history if known

e-Referrals Service Selection

  • Specialty: Ear, Nose & Throat
  • Clinic Type: Nose/Sinus
  • Service: DRSS-Northern-Ear Nose and Throat - Devon ICB- 15N

Referral Form

DRSS Referral Form

Evidence

NICE guideline 69

EPOS primary care guidelines Thomas et.al 2008

Pathway Group

This guideline has been signed off on behalf of NHS Devon.

Publication date: November 2017

Reviewed: April 2024